Role of detection method in predicting breast cancer survival: analysis of randomized screening trials
Y Shen, Y Yang, LYT Inoue, MF Munsell… - Journal of the …, 2005 - academic.oup.com
Background: Screening mammography detects breast cancers earlier than those detected
symptomatically, and so mammographically detected breast cancers tend to have better …
symptomatically, and so mammographically detected breast cancers tend to have better …
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: a pooled analysis of 4 randomized controlled …
…, AH Kadish, PJ Kudenchuk, DB Mark, LYT Inoue… - American heart …, 2017 - Elsevier
Background Primary prevention implantable cardioverter defibrillator (ICD) reduce all-cause
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …
mortality by reducing sudden cardiac death. There are conflicting data regarding whether …
Estimation of breast cancer overdiagnosis in a US breast screening cohort
Background: Mammography screening can lead to overdiagnosis—that is, screen-detected
breast cancer that would not have caused symptoms or signs in the remaining lifetime. There …
breast cancer that would not have caused symptoms or signs in the remaining lifetime. There …
Primary prevention implantable cardioverter defibrillators in patients with nonischemic cardiomyopathy: a meta-analysis
…, GC Fonarow, JA Joglar, LYT Inoue… - JAMA …, 2017 - jamanetwork.com
Importance Conflicting data have emerged on the efficacy of implantable cardioverter
defibrillators (ICDs) for primary prevention of sudden cardiac death (primary prevention ICDs) in …
defibrillators (ICDs) for primary prevention of sudden cardiac death (primary prevention ICDs) in …
Seamlessly expanding a randomized phase II trial to phase III
A sequential Bayesian phase II/III design is proposed for comparative clinical trials. The
design is based on both survival time and discrete early events that may be related to survival …
design is based on both survival time and discrete early events that may be related to survival …
Outcomes of implantable cardioverter-defibrillator use in patients with comorbidities: results from a combined analysis of 4 randomized clinical trials
…, AH Kadish, PJ Kudenchuk, DB Mark, LYT Inoue… - JACC: Heart Failure, 2014 - jacc.org
Objectives : The aim of this study was to determine if the benefit of implantable cardioverter-defibrillators
(ICDs) is modulated by medical comorbidity. Background : Primary prevention …
(ICDs) is modulated by medical comorbidity. Background : Primary prevention …
Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death in CKD: a meta-analysis of patient-level data from 3 randomized trials
…, PJ Kudenchuk, DB Mark, PL Hess, LYT Inoue… - American journal of …, 2014 - Elsevier
Background The benefit of a primary prevention implantable cardioverter-defibrillator (ICD)
among patients with chronic kidney disease is uncertain. Study Design Meta-analysis of …
among patients with chronic kidney disease is uncertain. Study Design Meta-analysis of …
Survival benefit of the primary prevention implantable cardioverter-defibrillator among older patients: does age matter? An analysis of pooled data from 5 clinical trials
…, AJ Moss, R Steinman, LYT Inoue… - … Quality and Outcomes, 2015 - Am Heart Assoc
Background— The impact of patient age on the risks of death or rehospitalization after primary
prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods …
prevention implantable cardioverter-defibrillator (ICD) placement is uncertain. Methods …
Individualized estimates of overdiagnosis in screen-detected prostate cancer
Background The chance that a prostate cancer detected by screening is overdiagnosed (ie,
it would not have been detected in the absence of screening) can vary widely depending on …
it would not have been detected in the absence of screening) can vary widely depending on …
Future research prioritization in cardiac resynchronization therapy
Background Although cardiac resynchronization therapy (CRT) is effective for some patients
with heart failure and a reduced left ventricular ejection fraction (HFrEF), evidence gaps …
with heart failure and a reduced left ventricular ejection fraction (HFrEF), evidence gaps …